Literature DB >> 16490345

Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.

Emad Afrasiabi1, Tomas Blom, Elina Ekokoski, Raimo K Tuominen, Kid Törnquist.   

Abstract

Several sphingolipid derivatives, including sphingosylphosphorylcholine (SPC), regulate a multitude of biological processes. In the present study we show that both human thyroid cancer cells (FRO cells) and normal human thyroid cells express G protein-coupled receptor 4 (GPR4) and ovarian cancer G protein-coupled receptor 1 (OGR1), putative SPC-specific receptors. In FRO cells SPC evoked a concentration-dependent increase in intracellular free calcium concentration ([Ca2+]i) in a calcium containing, but not in a calcium-free buffer. Sphingosine 1-phosphate (S1P) evoked an increase in [Ca2+]i in both a calcium containing and a calcium-free buffer. The phospholipase C (PLC) inhibitor U 73122 potently attenuated the effect of SPC, suggesting that effects of SPC were mediated by a G protein coupled receptor. Overnight pretreatment of the cells with pertussis toxin did not affect the SPC-evoked response. Interestingly, SPC did not evoke an increase in inositol phosphates, although S1P did so. Furthermore, in cells pretreated with thapsigargin to deplete intracellular calcium stores, SPC still evoked an increase in [Ca2+]i, suggesting that SPC mainly evoked entry of extracellular calcium. When the cells were pretreated with the protein kinase C (PKC) inhibitor GF 109203X, or when the cells were pretreated with PMA for 24 h, the SPC-evoked calcium entry was attenuated. Thus, the SPC-evoked calcium entry was apparently dependent on PKC. In sharp contrast, the increase in [Ca2+]i evoked by S1P was not sensitive to GF 109203X. Furthermore, the calcium entry evoked by the diacylglycerol analog 1-oleoyl-2-acetyl-sn-glycerol was not inhibited by GF 109203X. In addition, SPC decreased the incorporation of 3H-thymidine in a concentration-dependent manner in FRO cells. Taken together, SPC may be an important factor regulating thyroid cancer cell function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490345     DOI: 10.1016/j.cellsig.2006.01.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 2.  Sphingosylphosphorylcholine in cancer progress.

Authors:  Hong-Wei Yue; Qing-Chuan Jing; Ping-Ping Liu; Jing Liu; Wen-Jing Li; Jing Zhao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  The impact of bioactive lipids on cardiovascular development.

Authors:  Alexander Kleger; Stefan Liebau; Qiong Lin; Götz von Wichert; Thomas Seufferlein
Journal:  Stem Cells Int       Date:  2011-08-02       Impact factor: 5.443

Review 4.  GPR68: An Emerging Drug Target in Cancer.

Authors:  Shu Z Wiley; Krishna Sriram; Cristina Salmerón; Paul A Insel
Journal:  Int J Mol Sci       Date:  2019-01-28       Impact factor: 5.923

5.  Clinical data analysis reveals the role of OGR1 (GPR68) in head and neck squamous cancer.

Authors:  Wenlong Zhang; Yong Han; Weisha Li; Lin Cao; Libo Yan; Chuan Qin; Ran Gao
Journal:  Animal Model Exp Med       Date:  2020-03-18

6.  Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry.

Authors:  Vladimir A Snetkov; Gavin D Thomas; Bonnie Teague; Richard M Leach; Yasin Shaifta; Greg A Knock; Philip I Aaronson; Jeremy P T Ward
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.